411 related articles for article (PubMed ID: 6087215)
1. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
[TBL] [Abstract][Full Text] [Related]
2. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
Chapuy MC; Meunier P; Terrier M; David L; Vignon G
Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
Haddad JG; Caldwell JG
J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
[TBL] [Abstract][Full Text] [Related]
4. [Profile of a new calcitonin: carbocalcitonin-(Asu1,7) E-CT].
Nogarin L; Passarella E
Minerva Med; 1984 Jul; 75(30-31):1809-18. PubMed ID: 6207466
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of rectal administration of unmodified eel calcitonin in humans.
Nuti R; Martini G; Frediani B; Giovani S; Valenti R; Marcocci A; Ciappi A
Drugs Exp Clin Res; 1992; 18(9):395-400. PubMed ID: 1338592
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of Paget's disease of bone with salmon calcitonin.
Sturtridge WC; Harrison JE; Wilson DR
Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
Kuhlencordt F; Ringe JD; Kruse HP
Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of carbocalcitonin and salmon calcitonin, after endonasal administration in man.
Cecchettin M; Segre G
Biomed Pharmacother; 1995; 49(4):215-8. PubMed ID: 7669941
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
Deplante JP; Daumont A; Bouvier M; Lejeune E
Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Paget's disease with salmon calcitonin].
Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
[No Abstract] [Full Text] [Related]
11. [The hypocalcemia test, using human and salmon synthetic calcitonins. Paradoxical hypercalcemic responses. Responses in patients with Paget's disease treated with EHDP].
Alexandre C; Chapuy MC; Meunier P
Rev Rhum Mal Osteoartic; 1979 May; 46(5):335-42. PubMed ID: 116360
[TBL] [Abstract][Full Text] [Related]
12. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
[TBL] [Abstract][Full Text] [Related]
13. [A test for acute hypocalcemia using swine and salmon calcitonin].
Fournié A; Valverde C; Tap G; Bazerque JJ; Ayrolles C
Rev Rhum Mal Osteoartic; 1977 Feb; 44(2):91-8. PubMed ID: 847364
[TBL] [Abstract][Full Text] [Related]
14. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
Reginster JY; Jeugmans-Huynen AM; Albert A; Denis D; Franchimont P
J Bone Miner Res; 1988 Jun; 3(3):249-52. PubMed ID: 3213619
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses.
Kanis JA; Fitzpatrick K; Strong JA
Q J Med; 1975 Jul; 44(175):399-413. PubMed ID: 1101286
[TBL] [Abstract][Full Text] [Related]
16. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Nuti R; Turchetti V; Righi G; Vattimo A
Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
[TBL] [Abstract][Full Text] [Related]
19. [Development, chemistry, and clinical pharmacology of fully synthetic human calcitonin (author's transl)].
Hobitz H
Wien Klin Wochenschr; 1982 Feb; 94(3):67-75. PubMed ID: 7043901
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Paget's disease with salmon thyrocalcitonin. Cooperative double-blind study].
Bouvet JP
Nouv Presse Med; 1976 Apr; 6(17):1447-50. PubMed ID: 67592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
